Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
182 results about "Treatment monitoring" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Treatment management system
A system and a method for managing patient treatment stores in the database a patient history for each patient including data related to observations, test results, diagnoses, treatment regimen(s) and a treatment plan associated with the patient. The treatment plan is administered to the patient and medical device operating data related to the tasks of the associated treatment regimen is stored in the database. A reminder is issued if a task associated with the treatment regimen is not completed on time and the effectiveness of the treatment regimen is evaluated based upon the data stored in the database so that only effective treatment regimens are retained in the system. The system performs treatment planning, treatment monitoring, hospital monitoring, healthcare insurance billing, patient billing, research and analysis support, supply chain management and personnel scheduling.
Owner:ASHBEC
Remote detection of substance delivery to cells
InactiveUS20050112065A1Highly preventive effectIncreasing effect on proton relaxivityDiagnostics using lightDispersion deliveryLipid formationElectrochemical gradient
The present invention provides for the development of endocytosis-sensitive probes, and a remote method for measuring cellular endocytosis. These probes are based on the reduced water permeability of a nanoparticle or liposomal delivery system, and inherent degradability or disruption of barrier integrity upon endocytosis. The invention also provides for liposomes having combined therapeutic and diagnostic utilities by co-encapsulating ionically coupled diagnostic and therapeutic agents, in one embodiment, by a method using anionic chelators to prepare electrochemical gradients for loading of amphipathic therapeutic bases into liposomes already encapsulating an imaging agent. The invention provides for imaging of therapeutic liposomes by inserting a lipopolymer anchored, remotely sensing reporter molecules into liposomal lipid layer. The invention allows for an integrated delivery system capable of imaging molecular fingerprints in diseased tissues, treatment, and treatment monitoring.
Owner:SUTTER WEST BAY HOSPITALS
Combined radiation therapy/pet apparatus
InactiveUS20110092814A1Reduce unevennessSuppresses local sensitivity dropsDiagnostic recording/measuringTomographyBody axisParticle beam
A combined radiation therapy / PET apparatus includes: an open PET device having multi-ring detector rings that are opposed to each other in the direction of the body axis so as to leave a gap therebetween; and a radiation therapy apparatus for performing radiation therapy through the gap. When imaging the condition of an affected area and a treatment beam for monitoring in radiation therapy of irradiating the affected area with X-rays, gamma rays, or particle beams, the apparatus covers a region of interest in the irradiation field of the radiation therapy with the field-of-view of the open PET device, thereby making possible the positioning of the irradiation field and treatment monitoring using PET images.
Owner:NAT INST FOR QUANTUM & RADIOLOGICAL SCI & TECH
Combined radiation therapy/pet apparatus
InactiveUS8461539B2Reduce unevennessSuppresses local sensitivity dropsMaterial analysis by optical meansDiagnostic recording/measuringBody axisParticle beam
A combined radiation therapy / PET apparatus includes: an open PET device having multi-ring detector rings that are opposed to each other in the direction of the body axis so as to leave a gap therebetween; and a radiation therapy apparatus for performing radiation therapy through the gap. When imaging the condition of an affected area and a treatment beam for monitoring in radiation therapy of irradiating the affected area with X-rays, gamma rays, or particle beams, the apparatus covers a region of interest in the irradiation field of the radiation therapy with the field-of-view of the open PET device, thereby making possible the positioning of the irradiation field and treatment monitoring using PET images.
Owner:NAT INST FOR QUANTUM & RADIOLOGICAL SCI & TECH
Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
The present invention relates to novel cyclic peptides that may be conjugated with imaging agents, including novel imaging agents. Specifically, it includes c(KRGDf) NIR imaging compositions and novel cyclic HWGFTL polypeptides which may be used inter alia in NIR, MRI and nuclear imaging as well as therapy. Additionally, the invention includes novel imaging agents, such as TS-ICG derivatives. The invention also relates to methods of making and using such compounds. Such uses include both pre-operative and intraoperative detection of tumor cells and treatment monitoring.
Owner:BOARD OF RGT THE UNIV OF TEXAS SYST
Turbidimetric rapid detection kit for myocardial infarction nano-immunoenhancement and use method thereof
InactiveCN103185798ANo special training requiredNo need to waitMaterial analysis by observing effect on chemical indicatorBiological testingDisease courseBiomarker (petroleum)
The invention provides a turbidimetric rapid detection kit for myocardial infarction nano-immunoenhancement. The turbidimetric rapid detection kit comprises a reaction-detection integrated device, and a detection kit arranged in the reaction device, wherein a reagent R1, a reagent R2 and a calibrator are contained in the detection kit; simultaneously, quantitative detection for five important myocardial infarction-related biomarkers in one sample can be realized, and the five important biomarkers include content of troponin-I, content of D-dimer, content of myoglobin, content of hypersensitive C-reactive protein (hs-CRP) and content of heart-type fatty acid binding protein (FABP); and the turbidimetric rapid detection kit has an important clinical significance in the aspects of early diagnosis and disease course monitoring for myocardial infarction, treatment monitoring for medicines, and the like. The turbidimetric rapid detection kit provided by the invention realizes the integration of the reagents and the reaction device, and is simple, rapid and accurate to operate, high in sensitivity, strong in specificity, and low in detection cost; and the turbidimetric rapid detection kit is a detection / reagent measurement integrated kit suitable for outpatient and emergency treatment / clinical detection, and wide in instrument application range.
Owner:SUZHOU DIAGVITA BIOTECH
Dialysis treatment monitoring
InactiveUS20130131574A1Mechanical/radiation/invasive therapiesDrug and medicationsIntensive care medicineDialysis
This disclosure describes dialysis treatment monitoring systems and methods for operating dialysis treatment monitoring systems. The disclosure describes novel systems and methods for collecting and processing dialysis treatment information from a patient.
Owner:CARDIOCOM LLC
Graded diagnosis and treatment evaluating method based on data mining
ActiveCN105893766AIncrease the amount of effective dataSolve the problem that business data cannot be directly usedMedical data miningHealthcare resources and facilitiesMedical recordSorting algorithm
The invention discloses a graded diagnosis and treatment evaluating method based on data mining. The method comprises the steps: extracting essential information and diagnosis and treatment information on patients from medical records, associating the essential information and the diagnosis and treatment information with disease category information and medical institution information, and firstly, carrying out data cleaning and missing value filling so as to divide the patients into patients of different flow directions; then, calculating graded diagnosis and treatment monitoring indexes by using the data; portraying visiting behaviors and features of different patients by a GainRatioAttributeEva feature selection algorithm and a RIPPER sorting algorithm. According to the method, through evaluating graded diagnosis and treatment by qualitative indexes and quantified indexes, the defects in the current graded diagnosis and treatment evaluating methods that only the quantified indexes exist, the indexes are required to be reported layer upon layer, mis-reporting and confused reporting occur during reporting, and the tracking of reasons behind the indexes is absent are overcome; by using a data mining technology, graded diagnosis and treatment evaluation is more timely and accurate.
Owner:CHENGDU SHULIAN YIKANG TECH CO LTD
Diagnosis of (a risk of ) disease and monitoring of therapy
InactiveUS20070077578A1Improve reliabilityHigh sensitivitySugar derivativesMicrobiological testing/measurementDisease riskDisease cause
The invention provides a method for typing a sample of an individual suffering from, or at risk of suffering from, a disease and a method for monitoring treatment of an individual suffering from a disease comprising determining whether a sample from the individual comprises an expression product of AC133 in an amount that is indicative for the disease or for the treatment thereof. That amount is preferably quantified and compared with a reference value. In one aspect, the amount is compared with an amount of the expression product present in a sample that was obtained from the individual before treatment. Use of a nucleic acid molecule comprising at least part of a sequence of AC133, or an analogue thereof, for monitoring a treatment of an individual suffering from a disease is also provided, as well as a diagnostic kit comprising such nucleic acid molecule.
Owner:PRIMAGEN HLDG BV +1
Heat treatment monitoring system
A heat treatment monitoring system comprises a heat treatment machine comprising a heat treatment chamber, a double glass window comprising an inside window and an outside window, and an illumination apparatus for illuminating the inside of the heat treatment chamber, and a monitoring apparatus mounted to the heat treatment machine and comprising a camera to observe the inside of the heat treatment chamber through the inside window, wherein the visible transmittance of the outside window is lower than the visible transmittance of the inside window to reduce reflections within the double glass window structure and outside illumination effects on image processing of images recorded by the camera.
Owner:英戈·施托克格南特韦斯伯格
Obstructive sleep apnea syndrome treatment monitoring system
InactiveCN102499806AImprove hypoxiaImprove sleep qualitySnoring preventionBlood characterising devicesBlood oxygenationAnalysis center
The invention discloses an obstructive sleep apnea syndrome treatment monitoring system, and aims to solve the technical problem of eliminating harms brought by obstructive sleep apnea syndrome to a patient. The obstructive sleep apnea syndrome treatment monitoring system is provided with a collector, and a health care treatment mattress system used for sending collected patient information to a remote monitoring analysis center and receiving instructions of the remote monitoring analysis center, wherein the health care treatment mattress system is provided with a mattress; and inflatable air bags are arranged on the mattress. Compared with the prior art, the obstructive sleep apnea syndrome treatment monitoring system has the advantage that when a severe / moderate obstructive sleep apnea syndrome patient sleeps, the positions and the heights of the air bags in the mattress are remotely controlled and adjusted according to the prompt of an analysis signal of abnormal blood oxygenation content, so as to help the patient to adjust the sleep posture, open a respiratory tract and comprehensively improve the obstructive sleep apnea syndrome hypoxia phenomenon occurring to the patient in the sleep process; and the obstructive sleep apnea syndrome treatment monitoring system has the characteristics that paralysis is prevented, the sleep quality of the patient is improved, the falling-preventing air bags are provided, and sleep safety of the patient is guaranteed.
Owner:邱晨 +1
Difunctional tumor diagnosis reagent and method thereof
ActiveCN102778567AEasy to operateIn-vivo radioactive preparationsMicrobiological testing/measurementCancer cellSignalling molecules
The invention relates to a difunctional tumor diagnosis reagent and a method thereof, and belongs to the nano-technological field, the biological bionic field, and the immunology and biomedicine crossing field. The invention especially provides the difunctional tumor diagnosis reagent which is composed of a protein shell for specifically identifying cancer tissues and / or cancer cells and an inorganic nanometer core having a peroxidase catalytic activity. The invention also provides a kit comprising the reagent, and a method for detecting tumors in an individual through using the reagent. The difunctional tumor diagnosis reagent and the method can be used for cancer screening, early-stage diagnosis, treatment monitoring, cancer cell metastasis analysis, postoperative recurrence evaluation or basic cancer researches. The difunctional tumor diagnosis reagent integrates two functions comprising tumor specific identification and coloration into one, and enables the tumor specific identification and the coloration to be completely in a one step manner without the marking of a secondary antibody, a tertiary antibody or HRP or a signal molecule, and the operation is simple and convenient.
Owner:重庆康巨全弘生物科技有限公司
New applications of antibody of GDF15 (Growth differentiation factor 15) protein
ActiveCN101852804AMicrobiological testing/measurementImmunoglobulins against growth factorsSerodiagnosesDisease
The invention discloses new applications of an antibody of GDF15 (Growth differentiation factor 15) protein. The invention provides the following three applications of the antibody of the GDF15 protein: 1. the application in preparing a reagent for assisting to identify a hepatitis C patient or a hepatitis B patient; 2. the application in preparing a reagent kit for assisting to identify the hepatitis C patient or the hepatitis B patient; and 3. the application in preparing a reagent kit for assisting to identify the hepatitis C progress of the hepatitis C patient, wherein the hepatitis C progress is chronic hepatitis C, hepatitis C cirrhosis or liver cancer. On the basis of the three applications, the antibody of the GDF15 protein can be prepared into three reagent kits. The reagent kit can be used for the serological diagnosis of viral hepatitis (the hepatitis C or the hepatitis B) and judging the disease progress (the chronic hepatitis C, the hepatitis C cirrhosis or the liver cancer) and for prognosis and viral hepatitis treatment monitoring and has great value for the diagnosis and the treatment of the hepatitis C and the hepatitis B.
Owner:INST OF PATHOGEN BIOLOGY CHINESE ACADEMY OF MEDICAL SCI
Treatment monitoring tool
A tool for monitoring a course of treatment for a patient, including standards of care making up the course of treatment. The tool permits tracking of multiple patients, their diagnoses, corresponding treatment regimens, and status of those regimens. Once a diagnosis is selected by a physician, the embodiment may list the various steps and / or actions undertaken in a recommended course of treatment for that diagnosis. Such steps / actions can include tests to be performed on the patient, drugs or prescriptions to be prescribed to the patient, physical activity to be undertaken by the patient, assessments to be made by a practitioner, environmental factors to be applied to the patient and so forth. The tool also lists particular standards of care for a given diagnosis, as well as which standards of care are incomplete. The tool may also present a patient's location.
Owner:SWEDISH HEALTH SERVICES
5-Hydroxymethylcytosine as a biomarker for early detection, treatment and prognostic monitoring of cancer
InactiveUS20120122087A1Accurate confirmationMicrobiological testing/measurementBiological testingPrognostic predictionOncology
The present invention is related to the use of 5-hydroxymethylcytosine or a biomolecule having general structure of 5-hydroxymethycytosine as a biomarker for the detection, treatment monitoring, and prognostic prediction of cancer.
Owner:LI WEIWEI +1
Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes
InactiveUS20100075344A1Highly reproducible resultImprove signal-to-noise ratioDisease diagnosisBiological testingCancer cellCancers diagnosis
The invention relates to the diagnosis, monitoring, prognosis, and / or prediction of cancer utilizing the detection or measurement of glycan-protein interactions, particularly glycan-antibody interactions. The invention relates to carbohydrate-containing molecules that are utilized in bioanalytical systems, methods and kits for detecting neoplasia and methods related thereto and based thereon. In an exemplary embodiment glycans or glycopolymers are carried in an array, on beads or in a microfluidic system for diagnostic screening for risk of neoplasia, the existence of neoplasia in a patient, or for treatment monitoring. In such an embodiment, the bioanalytic system identifies binding interactions between molecules in a patient test sample (e.g., glycan compositions) and the glycans or glycopolymers. The glycan-binding compositions may be used to generate an immune response against cancer cell epitopes. Alternatively, antibody therapeutics can be developed that are useful for binding to glycan compositions on a cell surface.
Owner:VUSKOVIC MARKO +1
Methods and arrangements for analysis, diagnosis, and treatment monitoring of vocal folds by optical coherence tomography
InactiveUS20110224541A1Enhance the imageStable phonationBronchoscopesLaryngoscopesSingle cycleComputer science
Exemplary embodiments of an apparatus and a method can be provided. For example, a first information can be obtained for at least one signal that is (i) at least partially periodic and (ii) associated with at least one structure. In addition, a second information associated with the structure can be generated at multiple time points within a single cycle of the at least one signal. The second information can include information for the structure below a surface thereof. Further, it is possible to generate a third information based on the first information and the second information, where the third information is associated with at least one characteristic of the structure.
Owner:THE GENERAL HOSPITAL CORP
System for monitoring treatment of ischemic cerebrovascular disorder on the basis of image information
InactiveCN105678762AComparableEasy to upgradeImage enhancementImage analysisCerebrovascular disorderTherapeutic effect
The invention discloses a system for monitoring treatment of ischemic cerebrovascular disorder on the basis of image information. The system comprises: a clinical image processing module, a before-treatment and after-treatment image analysis module, and a treatment monitoring module. The clinical image processing module is used for performing importing, saving, format converting, grouping and image normalizing to clinic cerebral blood flow perfusion images, and generating cerebral blood flow perfusion templates; the before-treatment and after-treatment image analysis module is used for performing contrastive analysis to cerebral blood flow perfusion sequential images before clinical treatment and after clinical treatment, computing and obtaining quantitative parameters for therapeutic effect evaluation; the treatment monitoring module is used for selecting the quantitative parameters, establishing the relation between the quantitative parameters and traditional clinic assessment of recovery level, generating a specialist judging module of therapeutic effect evaluation, and monitoring the treatment process for ischemic cerebrovascular disorder on the basis of the specialist judging module.
Owner:SICHUAN UNIV
Treatment and diagnosis of metastatic prostate cancer with inhibitors of epidermal growth factor receptor (EGFR)
InactiveUS20100203043A1BiocidePeptide/protein ingredientsProstate cancerHuman epidermal growth factor receptor
The present invention relates to a method for the treatment, prevention and / or diagnosis of metastatic prostate cancer. More specifically inhibitors of Epidermal Growth Factor Receptor (EGFR) are used in the preparation of a pharmaceutical composition for treating or preventing metastatic prostate cancer. The EGFR inhibitors can for instance be EGFR inhibitors, EGFR signaling inhibitors and / or inhibitors of kinases downstream of EGFR kinases. The EGFR inhibitors can also be used in detection, screening, prediction and treatment monitoring methods for metastatic prostate cancer.
Owner:RIKSHOSPITALET RADIUMHOSPITALET HF +1
Sleep breath state signal acquisition device based on biological resistance and monitoring system
InactiveCN104771166AEasy to wearSuitable for home useSurgeryAcoustic sensorsBiological resistanceMedical treatment
Owner:SEALAND TECH CHENGDU
Radioactive ray monitoring and treating system
ActiveCN105342631APrecise positioningImprove real-time performanceRadiation diagnosticsX-ray/gamma-ray/particle-irradiation therapyGratingMedicine
The invention discloses a radioactive ray monitoring and treating system. The radioactive ray monitoring and treating system comprises a location monitoring device, a movement monitoring device, a treating monitoring device, a data processing device and an accelerator control device. The location monitoring device is used for obtaining location data of a patient by monitoring a magnetic field of a body surface location corresponding to an area where tumors of the patient are located; the movement monitoring device is used for obtaining location data of a target area and an organ at risk by monitoring a magnetic filed of an in-vivo location corresponding to an area where the tumors and / or the organic at risk of the patient is located; the treating monitoring device is used for obtaining blade location data by monitoring a magnetic field of blade locations of a multi-blade collimator of an accelerator; the data processing device is used for judging whether the patient location data, the location data of the target area and the organ at risk and the blade location data all met preset location requirements or not and sending out an instruction used for controlling the accelerator control device to start or stop irradiation according to a judgment result; the accelerator control device is used for starting or stopping radiation treatment according to the instruction sent out by the data processing device. According to the radioactive ray monitoring and treating system, a magnetic localization mode is adopted, and the accuracy of radiation treatment is improved.
Owner:PEKING UNIV FIRST HOSPITAL
Cloud-based ophthalmic eyelid treatment monitoring system and methods of the same
PendingUS20190142677A1Pliable and strongGood shape retentionUltrasound therapyParticular environment based servicesThermal energySensor array
Embodiments provide cloud-based ophthalmic eyelid treatment monitoring systems and cloud-based methods for monitoring ophthalmic eyelid treatment. The monitoring system includes a moldable warming device, a monitor, and a cloud server. The moldable warming device includes a heating disc, a resonance frequency stimulation vibration generator (RFSVG), a coupling device, a mask, and a sensor array. The mask is configured to hold the heating disc, the RFSVG, and the coupling device for use in parallel utility. The sensor array is configured to generate a data stream responsive to a vibration and heating profile of a user's individual patient eyelid and periorbital three-dimensional anatomy and surface topography. The monitor is configured to receive the data stream from the sensor array and configured to transmit the data stream to the cloud server. The cloud server is configured to process the data stream so as to determine tuning parameters of the vibration and heating profile of the user's individual patient eyelid and periorbital three-dimensional anatomy and surface topography, and configured to transmit the tuning parameters to the monitor. The monitor is configured to receive the tuning parameters from the cloud server, configured to display information related to the tuning parameters, and configured to transmit the tuning parameters to the moldable warming device. The moldable warming device is configured to receive the tuning parameters from the monitor and configured to generate thermal and vibratory energy according to the tuning parameters.
Owner:EYEDETEC MEDICAL
Microglia Microvesicles Contained MicroRNA-Based Methods For The Diagnosis, Prognosis And Treatment Monitoring Of Neurological, Neurodegenerative And Inflammation-Based Diseases
ActiveUS20190249250A1Microbiological testing/measurementDNA/RNA fragmentationMicroRNAVitro diagnostics
The present invention describes a method for the in vitro diagnosis, prognosis and / or treatment monitoring of neurodegenerative, neurological and inflammation-based diseases, wherein the method comprises the steps: a) isolating microglial microvesicles (MVs) from biological fluids obtained from an individual; b) collecting the microRNA (miRNA) contained into said MVs; c) determining the expression profile of a predetermined set of miRNA; d) comparing said expression profile to one or several reference expression profiles, wherein the comparison of said determined expression profile to said one or several reference expression profiles allows for the diagnosis, prognosis and / or treatment monitoring of the disease.
Owner:BRAINDTECH SPA
Positron emitting radionuclide labeled peptides for human uPAR PET imaging
ActiveUS9884131B2Improve featuresHigh and specific tumor uptakePeptide/protein ingredientsRadioactive preparation carriersDiseaseImaging biomarker
There is provided a positron-emitting radionuclide labelled peptide for non-invasive PET imaging of the Urokinase-type Plasminogen Activator Receptor (uPAR) in humans. More specifically the invention relates to human uPAR PET imaging of any solid cancer disease for diagnosis, staging, treatment monitoring and especially as an imaging biomarker for predicting prognosis, progression and recurrence.
Owner:CURASIGHT APS
Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (PD)
ActiveUS20160273043A1Reducing and eliminating degradationNervous disorderMicrobiological testing/measurementBody fluidTreatment monitoring
The invention is directed to methods for early diagnosis, progression and treatment monitoring of Parkinson's disease (PD) and its differentiation from other neurodegenerative diseases by quantifying brain-enriched miRNA in bodily fluids.
Owner:DIAMIR
Kit for detecting content of MR-1S (Myofibrillogenesis Regulator-1S) in human plasma and preparation method thereof
The invention belongs to the technical field of biomedical inspection, and particularly relates to an enzyme-linked immunosorbent assay kit for detecting the content of Myofibrillogenesis Regulator-1S (MR-1S). The enzyme-linked immunosorbent assay kit consists of the following reagents: an anti-human MR-1S antibody-precoated microplate or MR-1S antigen-precoated microplate; a bottle of anti-human MR-1S antibody enzyme-marked solution; MR-1S standard solutions of serial concentrations; a bottle of positive quality control solution; a bottle of negative quality control solution; a bottle of normal saline; cleaning mixture; sample diluent; blocking solution; substrate solution; and stop solution. Compared with the prior art, the invention has the advantages that: the detected result of the established kit shows that the kit can quantitatively detect the concentration of MR-1S, and the detected result can reflect the change range and the development trend of human MR-1S and meets the requirements of clinical diagnosis and treatment monitoring, moreover, an assay can be fulfilled in 120 minutes, the reagents and the method are stable, and are easy to operate, the sensitivity is high, the specificity is stronger, and the kit has a better clinical application prospect.
Owner:上海永昶医学诊断用品有限公司 +1
Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins
Owner:GUANGZHOU INNO-ENMAI BIOMEDICAL TECH CO LTD
Stony desertification control effect multi-index monitoring and evaluating method based on multi-source remote sensing data
ActiveCN110553980AMonitoring SystemComprehensive monitoringMaterial analysis by optical meansUsing optical meansSensing dataTreatment effect
The invention discloses a stony desertification treatment effect multi-index monitoring and evaluating method based on multi-source remote sensing data. The method comprises the following steps: (1) acquiring high-medium-low multi-source remote sensing data before and after stony desertification treatment in a monitoring area according to actual requirements; (2) calculating the vegetation coverage FVC and the leaf area index LAI of different time phases of the stony desertification control area according to the remote sensing data obtained in the step (1); (3) carrying out binarization processing according to the change conditions of the vegetation coverage FVC and the leaf area index LAI obtained in the step (2); (4) obtaining a comprehensive change condition FL of the vegetation coverage and the leaf area index; and (5) constructing a stony desertification treatment effect evaluation system. According to the invention, the defect of monitoring the physiological state of the vegetation in the treatment area in the current rocky desertification treatment monitoring is overcome, and the beneficial effect of monitoring the treatment situation more systematically and comprehensivelyis achieved.
Owner:CENT SOUTH UNIV +1
Tooth orthodontic treatment monitoring method based on intraoral image and three-dimensional model
InactiveCN111685899AImprove segmentation efficiencyImprove accuracyImage enhancementImage analysisAfter treatmentDental Gingiva
The invention discloses a tooth orthodontic treatment monitoring method based on an intraoral image and a three-dimensional model. The tooth orthodontic treatment monitoring method comprises the following steps that step 1, a preprocessed intraoral image and a dental jaw three-dimensional digital model of a patient at a P1 stage are obtained; step 2, tooth-gingiva and tooth-tooth segmentation is performed on the dental jaw three-dimensional digital model based on the intraoral image of the patient in the P1 stage, a segmented dental jaw three-dimensional digital model is obtained; step 3, a preprocessed intraoral image of the patient in a P2 stage is obtained; and step 4, the segmented dental jaw three-dimensional digital model is converted according to the intraoral image of the patient in the P2 stage, and a dental jaw three-dimensional digital model of the P2 stage and coordinate transformation data and morphological change data of the dental jaw models from the P1 stage to the P2 stage are generated. According to the tooth orthodontic treatment monitoring method based on the intraoral image and the three-dimensional model, coordinate transformation and form change conditions ofteeth of the patient after tooth orthodontic treatment can be known only by shooting the intraoral image, so that a scanner is prevented from being used for scanning an oral cavity after treatment.
Owner:上海银马科技有限公司
A test device for detecting an analyte in a saliva sample and method of use
InactiveUS20180106799A1Promote solubilizationImprove liquiditySurgeryVaccination/ovulation diagnosticsTherapy monitoringObstetrics
In some aspects, the present disclosure relates to a lateral flow test device, a kit or an instrument comprising the test device, and a method of using the test device, kit, or instrument for quantitatively detecting an analyte in a saliva sample, e.g., a saliva sample from a subject, for example, for assessing hormone(s), ovulation, pregnancy, and / or fertility for a user, e.g., hormonal, ovulation, pregnancy, fertility status, time window, trend, or therapy monitoring or guidance for the user.
Owner:BLUDIAGNOSTICS INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com